Aggressive angiomyxoma is a rare mesenchymal tumor involving the pelvic-perineal region. It occurs during the third and fourth decade of life and is predominantly seen in females. It presents clinically as a soft tissue mass in variable locations such as vulva, perianal region, buttock, or pelvis. Assessment of extent of the tumor by radiological evaluation is crucial for surgical planning; however, biopsy is essential to establish diagnosis. We present the radiological and pathological features seen in a 43-year-old female diagnosed with abdominal angiomyxoma with an unusual extension to the perineum.
INTRODUCTION
Aggressive angiomyxoma is a benign tumor affecting the pelvis and perineum, predominantly in women. Because of its presentation as a soft mass in various locations such as the vulva, perianal region, buttock, or pelvis, the tumor is often clinically misdiagnosed and initial surgery is usually unsuccessful in extirpating the mass. [1] It was first described in 1983 as a locally infiltrative lesion and was treated with wide local excision. [2] Angiomyxoma is described histologically as a mesenchymal tumor, composed of fibroblasts within a strong myxoid background. Vascular proliferation is also prominent, and virtually no mitoses takes place. [3] Vast majority of angiomyxomas afflict premenopausal females in their third or fourth decades of life with a female to male ratio of 6:1. [4, 5] The term aggressive refers to the locally infiltrative nature of the lesion and its tendency to recur. [6] Although, slow growing, they can attain large sizes (up to 60 cm) but are usually 10-20 cm in their greatest diameter and have a marked tendency to recur locally even decades after resection. [4] [5] [6] With an overall (up to 72%) good prognosis, they have a low metastatic capacity. [5, 6] A 40-year-old married female presented with a 2-year history of recurrent perineal swelling and hernia in the right buttock with mild distension and heaviness in the lower abdomen. She had normal menstrual history. Patient had been operated 16 months earlier as the same lesion was misdiagnosed as obturator hernia. Eight months after the surgery, the patient again felt a lump in the perineal region. Initially the lesion had been small and had progressively increased to its present size of 15 × 12 cm. Patient had felt increasing fullness and heaviness in her lower abdomen.
Her personal and family history was not significant and systemic examination was within normal limits. Her general examination revealed obesity with a weight of 92 kg with no other signifi cant fi nding. Local examination revealed slightly distended, soft, non-tender abdomen with no distinct lump/mass palpable, with no organomegaly and no free fl uid in the abdomen.
RADIOLOGICAL FEATURES
On ultrasonography of the abdomen, there was a large slightly heterogeneous mass lesion occupying almost the entire abdomen and pelvis [ 
PATHOLOGICAL FEATURES
A trucut needle biopsy was performed. The biopsy specimens were sent for histological examination. Hematoxylin and eosin staining of the sample revealed presence of scattered spindle cells in an abundant myxoid stroma rich in collagen fibers along with prominent blood vessel of varied caliber [ Figure 8 ]. Histopathological diagnosis was angiomyxoma.
The tumor was operated by abdominal and perineal approach. Intraoperative fi ndings revealed a large tumor occupying almost all of the abdomen lying just below the liver and spleen and originating from the pelvis [ Figure 9 ]. It was a firm, gelatinous, and fleshy mass. Its upper end was free and the mass was occupying the bilateral hypochondriac region. The mass had local infi ltration into mesorectal fascia and there was adhesion to the rectum. It was diffi cult to remove during operation and led to rectal injury during its removal. As a result, patient underwent sigmoid colostomy along with excision of the tumor and perineal hernia repair. A few months later, colostomy reversal surgery was done. Follow-up examinations carried out at 6-months and 12-months post-surgery showed no recurrence of the mass.
DISCUSSION
Aggressive angiomyxoma is a benign mesenchymal tumor of premenopausal females with variable presentation involving vulva, perianal region, buttock, or pelvis. Aggressive angiomyxomas display unusual growth patterns of translevator extension with growth around perineal structures. [1] It is a locally infiltrative lesion usually treated with wide local excision. [2] Histologically, it is described as mesenchymal tumor, composed of fibroblasts within a strong myxoid background and vascular proliferation. [3] Angiomyxomas grow slowly to a large size and have marked tendency to recur locally after resection. [6] It has low metastatic capacity with an overall good prognosis. [5, 6] Clinical diff erential diagnosis of a perineal mass in females includes vulvar abscess/neoplasm/cyst, Bartholin abscess, Gartner's duct cyst, vaginal cyst/polyp, vulvar edema, lipoma, canal of Nuck hernia, pelvic fl oor hernia, and vaginal prolapse.
Histopathological mimics are angiomyofibroblastoma, fibroma, myxofibrosarcoma, myxoid leiomyoma, lymphangioma, neurofi broma, malignant mesenchymoma, malignant fi brous histiocytoma, myxolipoma, sclerosing mesodermal tumor, leiomyosarcoma, and embryonal rhabdomyosarcomas. [7] Macroscopically angiomyxoma is unencapsulated, poorly circumscribed, and may blend imperceptibly with surrounding soft tissue; size is highly variable ranging from 1 to 60 cm. Tumor is often tan pink to tan gray, bulky and has a rubbery consistency with a glistening, gelatinous cut surface. Areas of congested blood vessels, hemorrhage or fibrosis may be present. On microscopic examination, angiomyxoma shows sparsely cellular tumor composed of eosinophilic stroma studded with numerously haphazardly arranged blood vessels that stand out against the myxoid background. Perivascular rings of condensed collagen may be prominent feature. Soft tissue infiltration is a frequent finding characterized by entrapment of muscle, nerve, and adipose tissue. Tumor cells are cytologically bland and have a spindle, ovoid, or stellate appearance with ill-defined cytoplasmic borders. Nuclear chromatin is evenly dispersed with minimal to no cellular atypia.
Immunohistochemistry does not have any specifi c marker for angiomyxoma but it does exhibit a characteristic pattern of reactivity. It generally shows diff use immunopositivity for vimentin and CD-34. Smooth muscle actin highlights myoid bundles and may be positive in individual tumor cells. S-100 reactivity is not a feature of aggressive angiomyxoma but maybe observed in entrapped nerves. Perhaps the most characteristic feature is estrogen receptor and progesterone receptor positivity. Labeling for ki-67 consistently demonstrates a low proliferative index.
Cytogenetic analysis and fl uorescent in situ hybridization have confirmed the presence of HMGA2 gene rearrangement in aggressive angiomyxoma and have shown that a subset of them, have the same molecular genetic background as other common mesenchymal tumors. [8] On imaging, sonography shows a mass that is hypoechoeic or frankly cystic. Angiography shows a generally hypervascular mass. CT shows a hypoattenuating mass. The tumor tends to grow around the structures of the pelvic fl oor without penetrating the muscles of the vagina and rectum. However, exceptions have been reported. On both CT and MR swirled and layered tissue within the tumor produced a distinctive appearance. This tissue shows slightly lower signal intensity than remainder of the tumor on T1-weighted MR images and enhances with gadolinium. On CT, the swirled appearance is evident only on enhanced scans. [1] High signal intensity on T2-weighted MR images may refl ect the myxomatous stroma of these tumors. [1] The first line of therapy for aggressive angiomyxoma is surgery, although achieving negative resection margins is diffi cult because of the infi ltrative nature of the tumor and the absence of a defi ned capsule. [9] Several reported attempts using chemotherapy and radiotherapy as part of the treatment for aggressive angiomyxoma have been disappointing, probably due to the low mitotic activity/growth fraction of cells. [10] Primary treatment with GnRH agonists has been carried out successfully as many of angiomyxomas are positive for estrogen and progesterone receptors. Whether treatment is with surgery, hormone therapy, or a combination of both, it is clear that angiomyxoma requires close, long-term follow up to monitor for recurrence and that the individualization of each case is essential for adequate management. [11] Multiple relapses may occur but metastases are unusual. One case of aggressive angiomyxoma in a young female with multiple local recurrences that metastasized to the lung has been reported by Stella et al. [12] CONCLUSION Aggressive angiomyxoma is a rare benign mesenchymal tumor of the abdomen, which can infiltrate locally and present unusually as perineal hernia. As it has variable clinical appearance, thorough radiological and pathological examination is essential to establish fi nal diagnosis. Local infiltration is common and great care is needed during surgical excision to avoid any visceral injury. Moreover, there is need for regular follow up at 6-month intervals because of the high rate of recurrence.
